December 2017

The use of technology and artificial intelligence (AI) in particular are likely be key to driving future drug discovery and development. In  it’s round up of 2017, Pharma Times highlights iDecide, being delivered by the digitalECMT as an innovative collaboration that allows patients to express their experiences and gives researchers access to data in real-time.

Remote patient monitoring, clinical algorithms, and artificial intelligence solutions all have the potential to move health technology and decision science from being about general wellness to an integral part of clinical decision-making in clinical trials. The digitalECMT is committed to changing the conduct of early clinical trials and engaging with patients so that they are co-scientists in both clinical research and digital innovation. We believe that our approach could radically change the way clinical trials are conducted in the future and we are taking steps towards making this a reality.